2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ALLEN, A. C. Articles by FEEHALLY, J. Search for Related Content PubMed PubMed Citation Articles by ALLEN, A. C. Articles by FEEHALLY, J.

Analysis of IgA1 O-Glycans in IgA Nephropathy by Fluorophore-Assisted Carbohydrate Electrophoresis

Department of Nephrology, Leicester General Hospital, Leicester, United Kingdom.

Correspondence to Dr. Alice C. Allen, Department of Nephrology, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, United Kingdom. Phone: +44 116 258 4124; Fax: +44 116 273 4989; E-mail: aa50{at}le.ac.uk

Abstract

Abstract. Abnormal O-glycosylation of IgA1 may contribute to pathogenic mechanisms in IgA nephropathy (IgAN). Observations of altered lectin binding to IgA1 in IgAN suggest that the O-glycan chains may be undergalactosylated, but precise structural definition of the defect has proved technically difficult, and it remains unconfirmed. This is the first study using fluorophore-assisted carbohydrate electrophoresis (FACE) to analyze IgA1 O-glycans in IgAN and controls. IgA1 was purified from serum, and the intact O-glycans were released by hydrazinolysis at 60°C. After re-N-acetylation, the glycans were fluorophore-labeled and separated by polyacrylamide gel electrophoresis. Sequential exoglycosidase digestions of IgA1 allowed identification of the different O-glycan bands on FACE gels, and their relative frequencies in IgA1 samples were measured by ultraviolet densitometry. Lectin binding of the IgA1 samples was also measured. In some patients with IgAN, FACE analysis demonstrated a significant increase in the percentage of IgA1 O-glycan chains consisting of single N-acetyl galactosamine (GalNAc) units rather than the more usual galactosylated and sialylated forms. This finding was confirmed using both desialylated IgA1 and enzymatically released O-glycans. Good correlation was also found between O-glycan agalactosylation on FACE analysis and IgA1 lectin binding in IgAN, supporting the value of lectins as tools for detection of this abnormality. This is the first study in which all of the predicted O-glycan forms of IgA1 have been analyzed simultaneously, and demonstrates that in IgAN, the IgA1 O-glycan chains are truncated, with increased terminal GalNAc. This abnormality has the potential to significantly affect IgA1 behavior and handling with pathogenic consequences in IgAN.

This article has been cited by other articles:

				J. Floege, F. Eitner, J. Barratt, A. C Smith, and J. Feehally Mutant mice provide new insight into the role of (mis-)glycation in IgA nephropathy and other glomerular diseases Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1518 - 1520. [Full Text] [PDF]

				T. Nishie, O. Miyaishi, H. Azuma, A. Kameyama, C. Naruse, N. Hashimoto, H. Yokoyama, H. Narimatsu, T. Wada, and M. Asano Development of Immunoglobulin A Nephropathy- Like Disease in {beta}-1,4-Galactosyltransferase-I-Deficient Mice Am. J. Pathol., February 1, 2007; 170(2): 447 - 456. [Abstract] [Full Text] [PDF]

				B. D. Oortwijn, A. Roos, L. Royle, D. J. van Gijlswijk-Janssen, M. C. Faber-Krol, J.-W. Eijgenraam, R. A. Dwek, M. R. Daha, P. M. Rudd, and C. van Kooten Differential Glycosylation of Polymeric and Monomeric IgA: A Possible Role in Glomerular Inflammation in IgA Nephropathy J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3529 - 3539. [Abstract] [Full Text] [PDF]

				A. C. Smith, K. Molyneux, J. Feehally, and J. Barratt O-Glycosylation of Serum IgA1 Antibodies against Mucosal and Systemic Antigens in IgA Nephropathy J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3520 - 3528. [Abstract] [Full Text] [PDF]

				A. C. Smith, J. F. de Wolff, K. Molyneux, J. Feehally, and J. Barratt O-Glycosylation of Serum IgD in IgA Nephropathy J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1192 - 1199. [Abstract] [Full Text] [PDF]

				P. J. M. van der Boog, C. van Kooten, A. van Seggelen, M. Mallat, N. Klar-Mohamad, J. W. de Fijter, and M. R. Daha An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2487 - 2493. [Abstract] [Full Text] [PDF]

				K. N. Lai, S. C. W. Tang, J.-Y. Guh, T.-D. Chuang, M. F. Lam, L. Y. Y. Chan, A. W. L. Tsang, and J. C. K. Leung Polymeric IgA1 from Patients with IgA Nephropathy Upregulates Transforming Growth Factor-{beta} Synthesis and Signal Transduction in Human Mesangial Cells via the Renin-Angiotensin System J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3127 - 3137. [Abstract] [Full Text] [PDF]

				A. Itoh, H. Iwase, T. Takatani, I. Nakamura, M. Hayashi, K. Oba, Y. Hiki, Y. Kobayashi, and M. Okamoto Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1108 - 1114. [Abstract] [Full Text] [PDF]

				E. Haddad, I. C. Moura, M. Arcos-Fajardo, M.-A. Macher, V. Baudouin, C. Alberti, C. Loirat, R. C. Monteiro, and M. Peuchmaur Enhanced Expression of the CD71 Mesangial IgA1 Receptor in Berger Disease and Henoch-Schonlein Nephritis: Association between CD71 Expression and IgA Deposits J. Am. Soc. Nephrol., February 1, 2003; 14(2): 327 - 337. [Abstract] [Full Text] [PDF]

				I. Kobayashi, F. Nogaki, H. Kusano, T. Ono, S. Miyawaki, H. Yoshida, and E. Muso Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2108 - 2116. [Abstract] [Full Text] [PDF]

				J. FLOEGE and J. FEEHALLY IgA Nephropathy: Recent Developments J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2395 - 2403. [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673